PlantPharm BioMed Ltd. © 2018 - All rights reserved.


PlantPharm has worked under exclusive agreements with the National Institutes of Health, Cornell University’s Boyce Thompson Institute, University of Wisconsin-Madison, Arizona State University and the world renowned Roswell Park Cancer Institute in the development of a platform technology to produce vaccines.

PlantPharm has successfully developed a proprietary platform for production of plants containing transgenic biopharmaceuticals (HBsAg) and has successfully deployed cGMP production requirements under the authorization of USDA/APHIS/BRS and FDA regulatory controls.